SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-22-005373
Filing Date
2022-04-25
Accepted
2022-04-25 16:13:58
Documents
15
Period of Report
2022-04-19
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K zivo_8k.htm   iXBRL 8-K 26286
2 EX-99.1 zivo_ex991.htm EX-99.1 4987
  Complete submission text file 0001654954-22-005373.txt   156908

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zivo-20220419.xsd EX-101.SCH 5830
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE zivo-20220419_lab.xml EX-101.LAB 14763
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE zivo-20220419_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zivo-20220419_pre.xml EX-101.PRE 9371
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zivo-20220419_def.xml EX-101.DEF 2103
9 EXTRACTED XBRL INSTANCE DOCUMENT zivo_8k_htm.xml XML 3615
Mailing Address 21 E. LONG LAKE ROAD SUITE 100 BLOOMFIELD HILLS MI 48304
Business Address 21 E. LONG LAKE ROAD SUITE 100 BLOOMFIELD HILLS MI 48304 (248) 452 9866
Zivo Bioscience, Inc. (Filer) CIK: 0001101026 (see all company filings)

IRS No.: 870699977 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40449 | Film No.: 22849818
SIC: 2836 Biological Products, (No Diagnostic Substances)